Table: Taiko Pharmaceutical - 9-MTH group results
08/02/2019 06:00
Feb 8 (Reuters)-
Taiko Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2018 Dec 31, 2017 Mar 31, 2019
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 7.19 6.71 9.36
(+7.1 pct) (+10.8 pct) (-1.1 pct)
Operating 1.90 1.88 1.63
(+0.8 pct) (+7.0 pct) (-12.2 pct)
Recurring 1.81 1.70 1.43
(+6.1 pct) (+4.1 pct) (-8.8 pct)
Net 1.29 1.15 1.01
(+11.5 pct) (-7.8 pct) (-7.8 pct)
EPS 90.07 yen 81.63 yen 70.94 yen
EPS Diluted 89.94 yen 81.28 yen
Ann Div 25.00 yen 25.00 yen
-Q2 div 10.00 yen NIL
-Q4 div 25.00 yen 15.00 yen
NOTE - Taiko Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T